Targeting BAFF and APRIL in MG

12 Nov 2026 0 comments

Dual BAFF and APRIL inhibition offers a distinct strategy for modifying B-cell and plasma-cell survival while potentially occupying a middle ground in treatment onset. Supported by Vor Bio Medical Affairs.

Source: NeurologyLive Published 12 Nov 2026 Imported 12 Nov 2026 Relevancy: Not reviewed

Read the article

Comments

No comments yet.

Unrestricted

All comments are reviewed before being published. Most comments are approved unless they are clearly inappropriate or unsafe.

Comments

Leave a comment